Lichen Planus
36
3
4
17
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
4 terminated out of 36 trials
81.0%
-5.6% vs benchmark
3%
1 trials in Phase 3/4
35%
6 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (36)
Mucosal and Nasal Involvement and Their Correlation With Smell and Taste Functions in Lichen Planus Patients
Koebner's Phenomenon in Psoriasis and Lichen Planus
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
Biomarkers for Oral Cancer
Determinants of Chronic Inflammatory Skin Disease Trajectories
Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)
Cellular and Molecular Biomarkers in Patients With Lichen Planus
Vaginal Ecosystem and Network in the United States Study
Laser Therapy in Women With Lichenoid Disorders
Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases
Systemic Treatment Options for Generalized Lichen Planus
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris
Treatment Of Oral Lichen Planus
Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus
a Flexible Wound Dressing for the Management of Genital Skin Conditions
Methods Validation Assessment for Study of Inflammatory Skin Disease
Topical Ruxolitinib Lichen Planus